Jingzhou Hu

8PUBLICATIONS
10CO-AUTHORS
Molecular targetsPredictive and prognostic markersImmunogenetics (incl. genetic immunology)Cancer therapy (excl. chemotherapy and radiation therapy)Periodontics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Mar 13, 2026
Context-Dependent Role of GDF15: GDF15+ Tumor-Associated Macrophages Suppress OSCC Progression by Enhancing Phagocytosis.

Xinyu Zhou, Zhihang Zhou, Houyu Ju

|Feb 09, 2026
Pembrolizumab With Anlotinib in Advanced Oral Mucosal Melanoma: A Retrospective Trial.

Yun Bi, Xinwei Yang, Yusheng Lu

|Jun 11, 2025
IL-4-STAT6-induced high Siglec-G/10 expression aggravates the severe immune suppressive tumor microenvironment and impedes the efficacy of immunotherapy in head and neck squamous cell carcinoma.

Wenyi Yang, Zhaoyang Guo, Houyu Ju

|Feb 18, 2025
Real-World Study of Later-Line Anlotinib in R/M Head and Neck Squamous Cell Carcinoma.

Houyu Ju, Yuanyuan Zhao, Minqi Zhao

|Oct 22, 2024
Porphyromonas gingivalis Promotes Oral Squamous Cell Carcinoma Progression by Modulating Autophagy.

Keyong Yuan, Shengming Xu, Guanglong Liu

|Jul 25, 2024
Fe3O4 Nanoparticles That Modulate the Polarisation of Tumor-Associated Macrophages Synergize with Photothermal Therapy and Immunotherapy (PD-1/PD-L1 Inhibitors) to Enhance Anti-Tumor Therapy.

Haishui Sun, Xiao Wang, Zhaoyang Guo

Pageof 2

Frequent Collaborators

2 joint publications

Haishui Sun

2 joint publications

Yuanchen Yin

2 joint publications

Guoxin Ren

1 joint publications

Guanglong Liu